These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 31926470)
1. The optimization of xanthine derivatives leading to HBK001 hydrochloride as a potent dual ligand targeting DPP-IV and GPR119. Li G; Meng B; Yuan B; Huan Y; Zhou T; Jiang Q; Lei L; Sheng L; Wang W; Gong N; Lu Y; Ma C; Li Y; Shen Z; Huang H Eur J Med Chem; 2020 Feb; 188():112017. PubMed ID: 31926470 [TBL] [Abstract][Full Text] [Related]
2. Discovery of novel xanthine compounds targeting DPP-IV and GPR119 as anti-diabetic agents. Li G; Huan Y; Yuan B; Wang J; Jiang Q; Lin Z; Shen Z; Huang H Eur J Med Chem; 2016 Nov; 124():103-116. PubMed ID: 27560285 [TBL] [Abstract][Full Text] [Related]
3. Rapid generation of novel benzoic acid-based xanthine derivatives as highly potent, selective and long acting DPP-4 inhibitors: Scaffold-hopping and prodrug study. Li Q; Meng L; Zhou S; Deng X; Wang N; Ji Y; Peng Y; Xing J; Yao G Eur J Med Chem; 2019 Oct; 180():509-523. PubMed ID: 31336309 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of tetrahydropyridopyrimidine derivatives as dual GPR119 and DPP-4 modulators. Fang Y; Zhang S; Wu W; Liu Y; Yang J; Li Y; Li M; Dong H; Jin Y; Liu R; Yang Z Bioorg Chem; 2020 Jan; 94():103390. PubMed ID: 31662212 [TBL] [Abstract][Full Text] [Related]
5. Optimization of the benzamide fragment targeting the S Deng X; Wang N; Meng L; Zhou S; Huang J; Xing J; He L; Jiang W; Li Q Bioorg Chem; 2020 Jan; 94():103366. PubMed ID: 31640932 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors. Li N; Wang LJ; Jiang B; Guo SJ; Li XQ; Chen XC; Luo J; Li C; Wang Y; Shi DY Bioorg Med Chem Lett; 2018 Jul; 28(12):2131-2135. PubMed ID: 29773502 [TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel DPP-4 Inhibitors. Li Q; Zhou M; Han L; Cao Q; Wang X; Zhao L; Zhou J; Zhang H Chem Biol Drug Des; 2015 Oct; 86(4):849-56. PubMed ID: 25787859 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors. Ji X; Su M; Wang J; Deng G; Deng S; Li Z; Tang C; Li J; Li J; Zhao L; Jiang H; Liu H Eur J Med Chem; 2014 Mar; 75():111-22. PubMed ID: 24531224 [TBL] [Abstract][Full Text] [Related]
10. Scaffold-based design of xanthine as highly potent inhibitors of DPP-IV for improving glucose homeostasis in DIO mice. Ran Y; Pei H; Xie C; Ma L; Wu Y; Lei K; Shao M; Tang M; Xiang M; Peng A; Wei Y; Chen L Mol Divers; 2015 May; 19(2):333-46. PubMed ID: 25672287 [TBL] [Abstract][Full Text] [Related]
11. Novel N-substituted 4-hydrazino piperidine derivative as a dipeptidyl peptidase IV inhibitor. Gupta RC; Chhipa L; Mandhare AB; Zambad SP; Chauthaiwale V; Nadkarni SS; Dutt C Bioorg Med Chem Lett; 2009 Sep; 19(17):5021-5. PubMed ID: 19643608 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of triazole based uracil derivatives as novel DPP-4 inhibitors. Li Q; Han L; Zhang B; Zhou J; Zhang H Org Biomol Chem; 2016 Oct; 14(40):9598-9611. PubMed ID: 27714283 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of xanthine derivatives on dipeptidyl peptidase 4. Lin K; Cai Z; Wang F; Zhang W; Zhou W Chem Pharm Bull (Tokyo); 2013; 61(4):477-82. PubMed ID: 23358258 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of azobicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes. Cho TP; Long YF; Gang LZ; Yang W; Jun LH; Yuan SG; Hong FJ; Lin W; Liang GD; Lei Z; Jing LJ; Shen GA; Hong SG; Dan W; Ying F; Ke YP; Ying L; Jun F; Tai MX Bioorg Med Chem Lett; 2010 Jun; 20(12):3565-8. PubMed ID: 20488702 [TBL] [Abstract][Full Text] [Related]
15. Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors. Tanwar O; Tanwar L; Shaquiquzzaman M; Alam MM; Akhter M Bioorg Med Chem Lett; 2014 Aug; 24(15):3447-51. PubMed ID: 24948564 [TBL] [Abstract][Full Text] [Related]
16. Design and Discovery of Novel 1,3,5-Triazines as Dipeptidyl Peptidase-4 Inhibitor against Diabetes. Wang Y; Tang X; Yi L Pharmacology; 2019; 103(5-6):273-281. PubMed ID: 30799431 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors. Ji X; Xia C; Wang J; Su M; Zhang L; Dong T; Li Z; Wan X; Li J; Li J; Zhao L; Gao Z; Jiang H; Liu H Eur J Med Chem; 2014 Oct; 86():242-56. PubMed ID: 25164763 [TBL] [Abstract][Full Text] [Related]
18. The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivo. Huan Y; Jiang Q; Li G; Bai G; Zhou T; Liu S; Li C; Liu Q; Sun S; Yang M; Guo N; Wang X; Wang S; Liu Y; Wang G; Huang H; Shen Z Sci Rep; 2017 Jun; 7(1):4351. PubMed ID: 28659588 [TBL] [Abstract][Full Text] [Related]